Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody

G. D. Cross, W. O. Schalla, J. S. Hancock, T. L. Hearn, S. O. Blumer, R. N. Taylor, Ronald Valdiserri

Research output: Contribution to journalArticle

Abstract

In 1986, a performance evaluation program at the Centers for Disease Control was implemented to assess the quality of performance of laboratories testing for human immunodeficiency virus type 1 antibody and to identify problems that occur during the testing process. Laboratories participating in the Centers for Disease Control Model Performance Evaluation Program for human immunodeficiency virus type 1 antibody testing furnished enzyme immunoassay results after they tested performance evaluation panels that were sent to them in August and November 1989. The panels consisted of 10 individual samples containing antibody-negative and antibody-positive samples, some of which were duplicates. Not all laboratories received the same panel of samples. Low false-negative and false-positive rates, as well as high intrashipment and intershipment reproducibility, indicate that most laboratories did not experience difficulty in testing performance evaluation samples sent to them in August and November 1989.

Original languageEnglish (US)
Pages (from-to)477-481
Number of pages5
JournalArchives of Pathology and Laboratory Medicine
Volume116
Issue number5
StatePublished - 1992
Externally publishedYes

Fingerprint

Immunoenzyme Techniques
HIV-1
Sensitivity and Specificity
Antibodies
Program Evaluation
Centers for Disease Control and Prevention (U.S.)

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody. / Cross, G. D.; Schalla, W. O.; Hancock, J. S.; Hearn, T. L.; Blumer, S. O.; Taylor, R. N.; Valdiserri, Ronald.

In: Archives of Pathology and Laboratory Medicine, Vol. 116, No. 5, 1992, p. 477-481.

Research output: Contribution to journalArticle

Cross, G. D. ; Schalla, W. O. ; Hancock, J. S. ; Hearn, T. L. ; Blumer, S. O. ; Taylor, R. N. ; Valdiserri, Ronald. / Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody. In: Archives of Pathology and Laboratory Medicine. 1992 ; Vol. 116, No. 5. pp. 477-481.
@article{7fae49ea422a45c6b5d2b793b10dd8f7,
title = "Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody",
abstract = "In 1986, a performance evaluation program at the Centers for Disease Control was implemented to assess the quality of performance of laboratories testing for human immunodeficiency virus type 1 antibody and to identify problems that occur during the testing process. Laboratories participating in the Centers for Disease Control Model Performance Evaluation Program for human immunodeficiency virus type 1 antibody testing furnished enzyme immunoassay results after they tested performance evaluation panels that were sent to them in August and November 1989. The panels consisted of 10 individual samples containing antibody-negative and antibody-positive samples, some of which were duplicates. Not all laboratories received the same panel of samples. Low false-negative and false-positive rates, as well as high intrashipment and intershipment reproducibility, indicate that most laboratories did not experience difficulty in testing performance evaluation samples sent to them in August and November 1989.",
author = "Cross, {G. D.} and Schalla, {W. O.} and Hancock, {J. S.} and Hearn, {T. L.} and Blumer, {S. O.} and Taylor, {R. N.} and Ronald Valdiserri",
year = "1992",
language = "English (US)",
volume = "116",
pages = "477--481",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "5",

}

TY - JOUR

T1 - Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody

AU - Cross, G. D.

AU - Schalla, W. O.

AU - Hancock, J. S.

AU - Hearn, T. L.

AU - Blumer, S. O.

AU - Taylor, R. N.

AU - Valdiserri, Ronald

PY - 1992

Y1 - 1992

N2 - In 1986, a performance evaluation program at the Centers for Disease Control was implemented to assess the quality of performance of laboratories testing for human immunodeficiency virus type 1 antibody and to identify problems that occur during the testing process. Laboratories participating in the Centers for Disease Control Model Performance Evaluation Program for human immunodeficiency virus type 1 antibody testing furnished enzyme immunoassay results after they tested performance evaluation panels that were sent to them in August and November 1989. The panels consisted of 10 individual samples containing antibody-negative and antibody-positive samples, some of which were duplicates. Not all laboratories received the same panel of samples. Low false-negative and false-positive rates, as well as high intrashipment and intershipment reproducibility, indicate that most laboratories did not experience difficulty in testing performance evaluation samples sent to them in August and November 1989.

AB - In 1986, a performance evaluation program at the Centers for Disease Control was implemented to assess the quality of performance of laboratories testing for human immunodeficiency virus type 1 antibody and to identify problems that occur during the testing process. Laboratories participating in the Centers for Disease Control Model Performance Evaluation Program for human immunodeficiency virus type 1 antibody testing furnished enzyme immunoassay results after they tested performance evaluation panels that were sent to them in August and November 1989. The panels consisted of 10 individual samples containing antibody-negative and antibody-positive samples, some of which were duplicates. Not all laboratories received the same panel of samples. Low false-negative and false-positive rates, as well as high intrashipment and intershipment reproducibility, indicate that most laboratories did not experience difficulty in testing performance evaluation samples sent to them in August and November 1989.

UR - http://www.scopus.com/inward/record.url?scp=0026720034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026720034&partnerID=8YFLogxK

M3 - Article

VL - 116

SP - 477

EP - 481

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 5

ER -